论文部分内容阅读
目前,我国养殖鱼虾的产量和规模已居世界首位。但随着放养密度的增加,养殖环境的逐渐恶化,养殖鱼虾的病害日趋严重,并已成为水产养殖业进一步发展的一大制约因素。因此,研究鱼虾患病的原因和防治方法,开发有效的水产新药,正越来越受到重视。中国星火总公司兴济生物技术研究所以中草药和抗菌素为原料,于近年研制成功的“鱼虾康”是一种防治鱼虾细菌病的新特效药。该产品于1992年初通过了河北省科委主持的技术鉴定,同年,被国家科委评为“国家级新产品”;1993年,又获河北省优质
At present, the production and scale of farmed fish and shrimp in China has ranked first in the world. However, with the increase of stocking density and the gradual deterioration of the culture environment, the diseases of farmed fish and shrimp are becoming more and more serious, and have become a major constraint factor for the further development of aquaculture. Therefore, the study of the causes of fish and shrimp diseases and prevention methods, the development of effective aquatic drugs, is more and more attention. China Xinghuo Corporation Xingji Biotechnology Research Institute of Chinese herbal medicines and antibiotics as raw materials, in recent years, the successful development of “fish and shrimp health” is a new cure for fish and shrimp bacterial disease. The product passed the technical appraisal conducted by Hebei Provincial Science and Technology Commission in early 1992. In the same year, it was appraised as “National New Product” by the State Science and Technology Commission. In 1993,